Periodical (Journal)

  1. PSIref
  2. Periodicals
ISSN  :   1756-283X ( Print )   |   1756-2848 ( Online )   Active

Journal Therapeutic Advances in Gastroenterology

Aim & Scope

Therapeutic Advances in Gastroenterology is an open access journal which delivers the highest quality peer-reviewed original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of gastrointestinal and hepatic disorders. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in gastroenterology and related disciplines, providing an online forum for rapid dissemination of recent research and perspectives in this area. [1]

Go to Website

2024 - VOLUME 17
63 RESULTS in 29 msec
2024-01-01

Transition is associated with lower disease activity, fewer relapses, better medication adherence, and lower lost-to-follow-up rate as opposed to self-transfer in pediatric-onset inflammatory bowel disease patients: results of a longitudinal, follow-up, controlled study

L Tóbi , B Prehoda , A Balogh , ... , Á Cseh

Therapeutic Advances in Gastroenterology , 2024 - VOLUME 17

10.1177/17562848241252947

0 91

2024-01-01

Infliximab monitoring in Crohn’s disease: a neural network approach for evaluating disease activity and immunogenicity

L Gomes , L Genaro , M Castro , ... , R Leal

Therapeutic Advances in Gastroenterology , 2024 - VOLUME 17

10.1177/17562848241251949

0 63

2024-00-00

Are anti-TNF agents safe in cirrhotics? The question remains unanswered.

S Giri

Therapeutic Advances in Gastroenterology , 2024 - VOLUME 17 , p 17562848211062790.

10.1177/17562848211062790

  0 3

2024-00-00

Long-term outcomes of cyclosporin induction and ustekinumab maintenance combination therapy in patients with steroid-refractory acute severe ulcerative colitis.

F Vitali , T Rath , E Klenske , ... , R Atreya

Therapeutic Advances in Gastroenterology , 2024 - VOLUME 17 , p 17562848231218555.

10.1177/17562848231218555

  0 38

2024-00-00

Advancements in endoscopic management of small-bowel polyps in Peutz-Jeghers syndrome and familial adenomatous polyposis.

Y Funayama , S Shinozaki , T Yano , H Yamamoto

Therapeutic Advances in Gastroenterology , 2024 - VOLUME 17 , p 17562848231218561.

10.1177/17562848231218561

  Review
0 48

2024-00-00

Association between hiatal hernia and Barrett's esophagus: an updated meta-analysis with trial sequential analysis.

S Ma , Z Tong , Y He , ... , X Qi

Therapeutic Advances in Gastroenterology , 2024 - VOLUME 17 , p 17562848231219234.

10.1177/17562848231219234

  0 89

2024-00-00

Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry.

M Calafat , P Torres , J Tosca-Cuquerella , ... , E Domènech

Therapeutic Advances in Gastroenterology , 2024 - VOLUME 17 , p 17562848231221713.

10.1177/17562848231221713

  0 25

2024-00-00

Treatment persistence and switching patterns of ABP 501 in European patients with inflammatory bowel disease.

R Jin , S Kruppert , F Scholz , ... , W Reinisch

Therapeutic Advances in Gastroenterology , 2024 - VOLUME 17 , p 17562848231222332.

10.1177/17562848231222332

  1 40

2024-00-00

Early infliximab trough levels in paediatric IBD patients predict sustained remission.

N Bevers , A Aliu , DR Wong , ... , PF van Rheenen

Therapeutic Advances in Gastroenterology , 2024 - VOLUME 17 , p 17562848231222337.

10.1177/17562848231222337

  0 30

2024-00-00

Economic impact of inflammatory bowel disease in Catalonia: a population-based analysis

E Brunet-Mas , B Garcia-Sagué , E Vela , ... , X Calvet

Therapeutic Advances in Gastroenterology , 2024 - VOLUME 17 , p 17562848231222344.

10.1177/17562848231222344

  0 40